PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Tonix Pharmaceuticals Holding Corp.
Filed: October 20, 2023
Period of Report: October 20, 2023
Accession Number: 0001387131-23-012488

View Document ↗ View on SEC.gov ↗